SLS Competitors & Alternatives
Compare Sellas Life Sciences Group Inc with similar stocks in the same industry
Biotechnology
SLS
Main Stock$14.98
Tradestie Score
54
Market Cap
$211.22M
Revenue Growth
-0.8%
Analyst Upside
-33.2%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMVT
Immunovant, Inc. Common Stock
|
$38.79
|
$2.85B | - | 61 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.45
|
$2.56B | 18.2 | 57 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$34.79
|
$2.44B | - | 62 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$65.44
|
$2.42B | - | 63 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$146.63
|
$2.41B | - | 58 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$37.65
|
$2.40B | - | 60 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.81
|
$2.37B | - | 59 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$132.91
|
$2.35B | - | 59 | Compare |
More SLS Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry